Keith Tolley and the team provide strategic consultancy, advice and training to pharmaceutical companies for their HTA submissions to UK bodies:
- The National Institute for Health and Clinical Excellence (NICE)
- The Scottish Medicines Consortium (SMC)
- The All Wales Medicine Strategy Group (AWMSG)
- The National Centre for Pharmacoeconomics (NCPE) in Ireland
and provide strategic reviews and consultancy on HTA evidence development plans for reimbursement needs alongside phase II and III clinical trials.